COPD exacerbation-reducing therapy (Circassia Pharmaceuticals)

N/A

Report date: 2025/03/18 18:22:12
NME

Base Information

Drug NameCOPD exacerbation-reducing therapy (Circassia Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNIOX Group Plc
China Registration ClassN/A

Develop Information

Active CompaniesNIOX Group Plc
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A